Provided by Tiger Fintech (Singapore) Pte. Ltd.

DexCom

77.21
+0.66000.86%
Volume:399.75K
Turnover:30.94M
Market Cap:30.28B
PE:53.99
High:77.84
Open:76.99
Low:76.62
Close:76.55
52wk High:93.25
52wk Low:57.52
Shares:392.16M
Float Shares:389.51M
Volume Ratio:1.45
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.43
EPS(LYR):1.46
ROE:22.83%
ROA:6.08%
PB:11.77
PE(LYR):52.74

Loading ...

Citi Sticks to Their Buy Rating for Dexcom (DXCM)

TIPRANKS
·
3 hours ago

DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
16 hours ago

Dexcom CEO Takes Medical Leave, Interim Roles Announced

TIPRANKS
·
Yesterday

Dexcom Inc - Mark Foletta Appointed Interim Chairman of Dexcom Board - SEC Filing

THOMSON REUTERS
·
Yesterday

Dexcom Inc - CEO Kevin R. Sayer Takes Temporary Medical Leave - SEC Filing

THOMSON REUTERS
·
Yesterday

Dexcom Inc - Jacob S. Leach Appointed Interim CEO of Dexcom - SEC Filing

THOMSON REUTERS
·
Yesterday

BRIEF-U.S. FDA- Dexcom Issues Correction For G7 Apps & One+ Apps

Reuters
·
Yesterday

U.S. FDA: Dexcom Issues Correction for G7 Apps & One+ Apps Due to Software Design Error That Does Not Alert Users of Unexpected Sensor Failure

THOMSON REUTERS
·
Yesterday

DexCom Inc. Awaits FDA and CE Mark Approval for Innovative Dexcom Smart Basal Feature

Reuters
·
Sep 15

FDA: Dexcom Issues Correction for G7 Apps and One+ Apps Due to a Software Design Error That Does Not Alert Users of Unexpected Sensor Failure

THOMSON REUTERS
·
Sep 13

Piper Sandler Remains a Buy on Dexcom (DXCM)

TIPRANKS
·
Sep 13

Bernstein Sticks to Their Buy Rating for Dexcom (DXCM)

TIPRANKS
·
Sep 13

DexCom Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Sep 11

Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day

THOMSON REUTERS
·
Sep 10

DexCom Inc. Director Kyle Malady Reports Disposal of Common Shares

Reuters
·
Sep 10

DexCom Inc. Stock Falls 3.1%, Underperforms Peers

Dow Jones
·
Sep 09

Sadie Stern, EVP and Chief HR Officer, Reports Disposal of Common Shares in DexCom Inc

Reuters
·
Sep 09

DexCom Faces Organic Issues, Competition Threat Despite 'Doing Everything' to Topple Headwinds, Oppenheimer Says

MT Newswires Live
·
Sep 08

Oppenheimer Downgrades DexCom to Perform From Outperform, Removes $102 Price Target

MT Newswires Live
·
Sep 08

Dexcom Inc. : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
Sep 08